HHS Secretary Robert F. Kennedy Jr. said in a press release that use of human fetal tissue from elective abortions in research will be replaced with “gold-standard science.” This shift aims to move ...

Moving Biotech (4MB), a clinical-stage biotechnology company and a spin-off of 4P-Pharma, developing a first-in-class disease-modifying osteoarthritis drug (DMOAD) for knee osteoarthritis, today ...

Explore how SCHQ’s government focus and SPLB’s corporate breadth shape risk profiles and income potential for long-term bond investors. SPLB and SCHQ both aim to provide diversified exposure to ...

The newly public Evommune shared data showing that EVO301, an IL-18 targeting protein, cleared symptoms comparably to Regeneron and Sanofi’s mega-blockbuster in a mid-stage atopic dermatitis clinical ...

Jharkhand Board Class 12 Biology Question Paper 2026 was conducted by the Jharkhand Academic Council (JAC) on 9 February 2026 (Evening Shift). The exam was held for a total of 70 marks with a writing ...

It's the latest in a string of science-focused deals that the pharmaceutical giant has made over the past 12 months as its ...

(NYSE American: OGEN) (“the “Company”) a clinical-stage biotechnology company developing brain-targeted therapeutics through proprietary intranasal delivery technology, today previewed its targeted ...

Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including ...

The Oklahoman's Student of the Week poll for the week of Feb. 9 is now live. The nominations for The Oklahoman's Student of ...

Goldman Sachs believes that Biohaven offers investors an under-the-radar opportunity to invest in a potentially best-in-class ...

In a board shakeup last month, Legend Biotech Corp (NASDAQ:LEGN) appointed chairman and executive director of a major shareholder, GenScript, Robin Meng, as a Class III director to serve until the ...